Should adults with autoimmune rheumatic conditions receive updated COVID-19 vaccines?

In an Arthritis & Rheumatology analysis of data on 60,980 U.S. adults with autoimmune rheumatic conditions who developed COVID-19 between December 2020 and August 2024, those who received booster or updated (2023–2024) COVID-19 vaccines were less likely to be hospitalized for COVID-19 than those who received only the initial vaccine series or were unvaccinated.

Read it at Medical Xpress ↗

← Front page